His comments come after Merck officially opened its new 120,000-square-foot research facility in the Greater Philadelphia ...

Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over the ...

Rahway, New Jersey-based Merck & Co., Inc. (MRK) is an international healthcare company that offers human health ...

Merck & Co. has poured out its Brunello data, revealing a mix of undifferentiated efficacy and concerning safety that led ...

CNBC’s Annika Kim Constantino sits down with Merck Chairman and CEO Rob Davis to discuss the company’s new manufacturing site ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

In the latest close session, Merck (MRK) was down 2.66% at $145.31. The stock fell short of the S&P 500, which registered a loss of 0.25% for the day. Elsewhere, the Dow saw a downswing of 0.86%, ...

Merck & Co. stock is supported by DBS’s Buy rating with a USD 180.00 price target as of September 12, 2026. The company reported Q2 2026 revenue of USD 16.6 billion, up 5.07 percent year over year.

Winrevair sales jumped 75% to $588 million in the quarter, while Merck’s Animal Health business grew 8% to $1.8 billion.

INTerpath-001 data to be presented in Presidential Symposium, featuring the first Phase 3 results for investigational ...

Merck trades at a single-digit P/E, reflecting underperformance but strong financials and a robust dividend yield near 3.9%. Keytruda’s ongoing success and expanded indications drive near-term results ...

Merck & Co., Inc. is currently listed on NYSE under MRK. One share of MRK stock can currently be purchased for approximately $145.60. Is Merck & Co., Inc. listed on the NASDAQ or NYSE? Merck & Co., ...